Apollo Endosurgery, Inc. (APEN): Price and Financial Metrics

Apollo Endosurgery, Inc. (APEN): $10.00

0.08 (+0.81%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

APEN Price/Volume Stats

Current price $10.00 52-week high $10.30
Prev. close $9.92 52-week low $3.49
Day low $9.92 Volume 1,658,800
Day high $10.00 Avg. volume 1,432,125
50-day MA $9.91 Dividend yield N/A
200-day MA $7.43 Market Cap 579.72M

APEN Stock Price Chart Interactive Chart >


Apollo Endosurgery, Inc. (APEN) Company Bio


Apollo Endosurgery, Inc. focuses on the design, development, and commercialization of medical devices for the treatment of obesity. The company offers endo-bariatric products, such as Orbera intragastric balloon system, a non-surgical alternative for the treatment of overweight and obese adults; and OverStitch, an endoscopic suturing system that enables endoscopic procedures by allowing physicians to place full-thickness sutures and secure the approximation of tissue through an Olympus dual-channel flexible endoscope. It also provides surgical products, including Lap-Band system, a system designed to provide minimally invasive long-term treatment of obesity; and accessories used in laparoscopic bariatric surgeries. The company is based in Austin, Texas.


APEN Latest News Stream


Event/Time News Detail
Loading, please wait...

APEN Latest Social Stream


Loading social stream, please wait...

View Full APEN Social Stream

Latest APEN News From Around the Web

Below are the latest news stories about APOLLO ENDOSURGERY INC that investors may wish to consider to help them evaluate APEN as an investment opportunity.

Apollo Endosurgery Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

Apollo Endosurgery ( NASDAQ:APEN ) Full Year 2022 Results Key Financial Results Revenue: US$76.9m (up 22% from FY...

Yahoo | April 1, 2023

Does This Valuation Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Imply Investors Are Overpaying?

Key Insights Apollo Endosurgery's estimated fair value is US$7.40 based on 2 Stage Free Cash Flow to Equity Apollo...

Yahoo | March 7, 2023

Analysts Are Downgrading These 10 Stocks

In this article, we will discuss the 10 stocks recently downgraded by analysts. If you want to see more such stocks on the list, you can directly visit Analysts Are Downgrading These 5 Stocks. Microsoft Corporation (NASDAQ:MSFT) is in the news after the company posted fiscal Q2 results. The company’s revenue outlook for the March […]

Yahoo | January 26, 2023

Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity

Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that the MERIT trial, published in The Lancet earlier this year(1), was selected as 2022 Top Story in Gastroenterology.(2) Additionally, the American Society for Metabolic and Bariatric Surgery (ASMBS) formally added four Apollo systems to its list of FDA Approved Bariatric Devices

Yahoo | December 13, 2022

Boston Scientific's (BSX) New Buyout to Expand its Portfolio

Boston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures.

Yahoo | November 30, 2022

Read More 'APEN' Stories Here

APEN Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 13.64%
5-year 161.78%
YTD N/A
2023 0.00%
2022 18.27%
2021 147.94%
2020 19.30%
2019 -17.39%

Continue Researching APEN

Want to see what other sources are saying about Apollo Endosurgery Inc's financials and stock price? Try the links below:

Apollo Endosurgery Inc (APEN) Stock Price | Nasdaq
Apollo Endosurgery Inc (APEN) Stock Quote, History and News - Yahoo Finance
Apollo Endosurgery Inc (APEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!